Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Thyroid Gland

The Thyroid Gland

The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...

Papillary Dermis

Papillary Dermis

Dermis
The dermis might be considered the "core" of the integumentary system, as distinct from the epidermis and hypodermis. It contains blood and lymph vessels, nerves, and other structures, such as hair follicles and sweat glands. The dermis is made of two layers of connective tissue that comprise an interconnected mesh of elastin and collagenous fibers, produced by fibroblasts.
Papillary Layer
The papillary layer is made of loose, areolar connective tissue, which means the collagen and...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quantifying TERT promoter mutations in tumor-derived DNA shed into the oral cavity as a potential biomarker for oral squamous cell carcinoma.

Frontiers in oncology·2026

Same author

Biomarkers: Which Ones Do We Really Need Today?

Breast care (Basel, Switzerland)·2023

Same author

A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients.

Acta bio-medica : Atenei Parmensis·2022

Same author

Remote vs in-person BRCA1/2 non-carriers test disclosure: patients' choice during Covid-19 pandemic restriction.

Familial cancer·2022

Same author

The Impact of Mediterranean Dietary Intervention on Metabolic and Hormonal Parameters According to <i>BRCA1/2</i> Variant Type.

Frontiers in genetics·2022

Same author

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma.

Molecular cancer·2022

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

BRAF in papillary thyroid carcinoma.

Salvatore Giovanni Lanzilotta¹, Luciano Grammatica, Angelo Paradiso

¹Istituto Tumori Giovanni Paolo, Bari, Italy.

Cellular Oncology : the Official Journal of the International Society for Cellular Oncology

|July 21, 2007

Summary

The BRAF gene, particularly its T1799A mutation, is crucial in papillary thyroid carcinoma (PTC) development and prognosis. Pre-operative BRAF mutation detection in fine-needle aspiration biopsy (FNAB) aids diagnosis and guides targeted cancer therapy.

More Related Videos

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Related Experiment Videos

Last Updated: Jul 13, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma

Published on: September 15, 2023

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Area of Science:

Oncology
Genetics
Molecular Biology

Background:

Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
The BRAF gene has emerged as a key player in PTC pathogenesis.
Specific mutations, like T1799A, are of significant interest.

Purpose of the Study:

To summarize the involvement of the BRAF gene in PTC.
To review the diagnostic and prognostic significance of the BRAF T1799A mutation.
To explore the utility of pre-operative BRAF mutation detection and its role in targeted therapy.

Main Methods:

Literature review and summary of existing research on BRAF gene in PTC.
Analysis of diagnostic and prognostic implications of BRAF T1799A mutation.
Discussion of pre-operative detection methods and therapeutic targeting.

Main Results:

The BRAF gene, especially the T1799A mutation, is frequently implicated in PTC.
BRAF mutation status holds diagnostic and prognostic value for PTC.
Pre-operative detection in FNAB specimens is feasible and informs treatment strategies.

Conclusions:

BRAF gene mutations are critical in papillary thyroid carcinoma.
Early detection of BRAF mutations in FNAB specimens improves diagnostic accuracy and prognostic assessment.
Targeting the BRAF gene offers a promising avenue for effective PTC therapy.